Tower Research Capital (TRC)’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.32K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $450 | Sell |
|
|||||
|
2024
Q3 | $7.04K | Buy |
|
|||||
|
2024
Q2 | $2.04K | Buy |
|
|||||
|
2024
Q1 | $4.75K | Buy |
|
|||||
|
2023
Q4 | $2.95K | Buy |
|
|||||
|
2023
Q3 | $11.5K | Buy |
|
|||||
|
2023
Q2 | $8.78K | Sell |
|
|||||
|
2023
Q1 | $12K | Buy |
|
|||||
|
2022
Q4 | $10K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $13K | Buy |
|
|||||
|
2022
Q1 | $15K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $82K | Buy |
|
|||||
|
2021
Q2 | $18K | Buy |
|